Authors: ZIMMERMAN SW OXTON LL BIDWELL D WAKEEN M

Citation: Sw. Zimmerman et al., LONG-TERM OUTCOME OF DIABETIC-PATIENTS RECEIVING PERITONEAL-DIALYSIS, Peritoneal dialysis international, 16(1), 1996, pp. 63-68

Authors: OXTON LL ZIMMERMAN SW ROECKER EB WAKEEN M

Citation: Ll. Oxton et al., RISK-FACTORS FOR PERITONEAL DIALYSIS-RELATED INFECTIONS, Peritoneal dialysis international, 14(2), 1994, pp. 137-144

Authors: BOHENEK WS JOHNSON CA ATESHKADI A OXTON LL ZIMMERMAN SW

Citation: Ws. Bohenek et al., EFFECT OF PERITONITIS ON PLASMA AND DIALYSATE ALPHA(1)-ACID GLYCOPROTEIN CONCENTRATIONS IN PERITONEAL-DIALYSIS PATIENTS, Clinical pharmacy, 12(8), 1993, pp. 602-605

Authors: ATESHKADI A JOHNSON CA OXTON LL HAMMOND TG BOHENEK WS ZIMMERMAN SW

Citation: A. Ateshkadi et al., PHARMACOKINETICS OF INTRAPERITONEAL, INTRAVENOUS, AND SUBCUTANEOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, American journal of kidney diseases, 21(6), 1993, pp. 635-642